The INHALE-1 study is a 26-week, open-label clinical trial that randomized 230 subjects to one of two groups: Afrezza or multiple daily injections (MDI) of rapid acting insulin analog (RAA ...

An curved arrow pointing right. Doctors have demonstrated what happens to your lungs when you inhale deeply, through an intriguing video experiment. Facebook page MEDspiration posted footage of an ...

(RTTNews) - MannKind Corporation (MNKD) Monday reported positive six-month results from its Phase 3 INHALE-1 study of Afrezza Inhalation Powder, a rapid-acting inhaled human insulin, in ...

Off with their heads have announced the release that they've been hinting about over the past two weeks. INHALE. EXHALE. SMILE. is a collection of songs that the band recorded as bandcamp digital ...

MannKind Corporation, a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced six-month ...

today announced six-month results from its Phase 3 INHALE-1 study of Afrezza (insulin human) Inhalation Powder in children and adolescents (aged 4-17 years of age). MannKind expects to submit a ...